Abstract

Protein composition at the plasma membrane is tightly regulated, with rapid protein internalization and selective targeting to the cell surface occurring in response to environmental changes. For example, ion channels are dynamically relocalized to or from the plasma membrane in response to physiological alterations, allowing cells and organisms to maintain osmotic and salt homeostasis. To identify additional factors that regulate the selective trafficking of a specific ion channel, we used a yeast model for a mammalian potassium channel, the K+ inward rectifying channel Kir2.1. Kir2.1 maintains potassium homeostasis in heart muscle cells, and Kir2.1 defects lead to human disease. By examining the ability of Kir2.1 to rescue the growth of yeast cells lacking endogenous potassium channels, we discovered that specific α-arrestins regulate Kir2.1 localization. Specifically, we found that the Ldb19/Art1, Aly1/Art6, and Aly2/Art3 α-arrestin adaptor proteins promote Kir2.1 trafficking to the cell surface, increase Kir2.1 activity at the plasma membrane, and raise intracellular potassium levels. To better quantify the intracellular and cell-surface populations of Kir2.1, we created fluorogen-activating protein fusions and for the first time used this technique to measure the cell-surface residency of a plasma membrane protein in yeast. Our experiments revealed that two α-arrestin effectors also control Kir2.1 localization. In particular, both the Rsp5 ubiquitin ligase and the protein phosphatase calcineurin facilitated the α-arrestin-mediated trafficking of Kir2.1. Together, our findings implicate α-arrestins in regulating an additional class of plasma membrane proteins and establish a new tool for dissecting the trafficking itinerary of any membrane protein in yeast.

Highlights

  • Protein composition at the plasma membrane is tightly regulated, with rapid protein internalization and selective targeting to the cell surface occurring in response to environmental changes

  • Mutation of Kir2.1, which abrogates its association with adaptin complex 1 (AP-1), a clathrin adaptor required for Golgi-to-plasma membrane trafficking, blunts Kir2.1 targeting to the plasma membrane and leads to Andersen–Tawil syndrome, which causes ventricular arrhythmias [13]

  • We show for the first time that the heterologous expression of the Kir2.1 potassium channel in trk1⌬ trk2⌬ yeast directly increases intracellular potassium

Read more

Summary

The abbreviations used are

Kϩ inward rectifying; ER, endoplasmic reticulum; ICP-MS, inductively coupled plasma mass spectrometry; FAP, fluorogen-activating protein; MVB, multivesicular body; ESCRT, endosomal sorting complexes required for transport; SCA, single-chain antibody; MG, malachite green; LatA, latrunculin A; a.u., arbitrary units; TM, transmembrane; AzC, azetidine-2-carboxylic acid; GST, glutathione S-transferase; SC, synthetic complete. The ␣-arrestins are a class of conserved protein adaptors that link specific cargo proteins to a ubiquitin ligase, known as Rsp, and facilitate protein sorting in the late secretory pathway [17,18,19,20,21,22] From this screen, we determined that three ␣-arrestins, Aly, Aly, and Ldb ( known as Art, Art, and Art1), promote Kir2.1dependent growth of yeast on low-potassium medium. To show directly that the overexpression of the ␣-arrestins increases Kir2.1 residence at the plasma membrane, we implemented an imaging technology that employs a fluorogen-activating protein (FAP) fusion to Kir2.1 This FAP reporter was first developed in yeast [23], surprisingly it has not been used to detect the residence of membrane proteins at the cell surface in this organism. Our findings pave the way for future investigations of ␣-arrestin regulation of Kir2.1 in human cells, expand the role of ␣-arrestins in regulating the residence of specific protein cargo, and demonstrate the general applicability of a new fluorescence imaging technology that can detect the levels of low abundance proteins at the yeast plasma membrane

Results
MG-ESTER
Cell impermeant dye - MG-B-TAU
Latrunculin A treated cells
Discussion
Experimental procedures
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call